Antimicrobial resistance already kills millions and is projected to get worse. But there is little incentive for Big Pharma to tackle the issue
Superbugs: why it’s so hard to stop the ‘silent pandemic’
Recent Posts
- Young trader who made $250mn on Russian crude sets sights on Guyana
- BP hails ‘exceptional’ quarter for oil traders as Iran war stokes volatility
- Virgin Atlantic boss says higher jet fuel prices are ‘here to stay’
- Geopolitical upheaval spurs family offices to open global branches
- OpenAI investors question $852bn valuation as strategy shifts
